Filing Flows › Yarrow Bioscience (YARW) › Recalls, complaints & regulation
Yarrow Bioscience (YARW): clinical trials
Yarrow Bioscience (YARW) beyond its filings: 1 active clinical trial.
Yarrow Bioscience's latest quarter
Yarrow Bioscience, Q2 2026: revenue $97K (+41% year over year), net loss $3.0M, operating cash flow −$2.0M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Yarrow Bioscience have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.